Revolution Medicines seeks to bolster case for its lead cancer drug Revolution Medicines on Saturday presented updated data to bolster the case for its lead cancer drug — designed to stop tumor growth by throttling back mutations in a common cell-signaling pathway. The drug, called RMC-4630, won’t shrink tumors very much on its own. The […]

Immune-stimulating drug before surgery shows promise in early-stage pancreatic cancer PHILADELPHIA–Giving early-stage pancreatic cancer patients a CD40 immune-stimulating drug helped jumpstart a T cell attack to the notoriously stubborn tumor microenvironment before surgery and other treatments, according to a new study from researchers in the Abramson Cancer Center (ACC) at the University of Pennsylvania. Changing […]

Trastuzumab Deruxtecan Sensitivity Associated With Various Levels of HER2-Expressing Gastric … Treatment with trastuzumab deruxtecan (Enhertu; DS-8201) showed promising sensitivity in patients with with HER2 moderate-, low-, and non-expressing gastric cancer, according to data from a study presented during the virtual AACR Annual Meeting 2021.1 Trastuzumab (Herceptin) and trastuzumab deruxtecan, at various concentrations, demonstrated cytostatic […]

Google Alert – cancer -horoscope Google Alert – cancer -horoscope Lung cancer risk prediction model lacks efficacy in diverse populations https://www.google.com/url?rct=j&sa=t&url=https://www.healio.com/news/primary-care/20210409/lung-cancer-risk-prediction-model-lacks-efficacy-in-diverse-populations&ct=ga&cd=CAIyHGM0YWY4ZDI3MTA1YWI2ODA6Y28uaW46ZW46SU4&usg=AFQjCNFBR3j0bFgKginlYhlOJ9raCtz0eg https://www.google.com/url?rct=j&sa=t&url=https://www.healio.com/news/primary-care/20210409/lung-cancer-risk-prediction-model-lacks-efficacy-in-diverse-populations&ct=ga&cd=CAIyHGM0YWY4ZDI3MTA1YWI2ODA6Y28uaW46ZW46SU4&usg=AFQjCNFBR3j0bFgKginlYhlOJ9raCtz0eg <div class=”article__content–header”> <div class=”article__posted-date”> <p> April 09, 2021 </p> <p> 2 min read </p> </div> </div> <div class=”mobile-trust-box”> <div class=”row”> <div class=”col-12 col-md-5 d-xl-none”> <div class=”trust-box”> <div class=”sources-disclosures”> <a class=”title collapsed” data-toggle=”collapse” data-target=”.trustbox-toggle” […]

Webinar on cancer prevention, treatment Rela Hospital will present The Hindu Wellness Series webinar on cancer prevention and treatment. The webinar will bring to the table discussions on whether cancer can be prevented, the preventable risk factors, PET/CT scan investigation, how costly treatment cancer treatment can be, and the age factor for taking up mammogram […]

Secondary Cytoreduction Followed by Chemotherapy May Improve PFS in Ovarian Cancer For patients with platinum-sensitive relapsed ovarian cancer, research found that secondary cytoreduction followed by chemotherapy was associated with statistically significant longer progression-free survival (PFS) rates when compared to chemotherapy alone, according to data published in Lancet Oncology. With these findings in mind, this cohort […]

Lung cancer risk prediction model lacks efficacy in diverse populations April 09, 2021 2 min read Source/Disclosures Disclosures: Shusted reports no relevant disclosures. Please see the study for all other authors’ relevant financial disclosures. ADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on Please provide your email address to receive […]